A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...
Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...
Neither clinical trials nor an application for federal approval from the Food and Drug Administration (FDA) are underway, meaning it's highly unlikely the state-manufactured insulin will be ...
This past year featured key developments in the prescription drug policy area, including the implementation of significant ...
A law that coaxed companies to lower the price of drugs came with ... including special food, medications and a glucose monitor. They are no longer facing the highest insulin price, but their ...